GS-441524 INFORMATION CENTER
Learn about GS-441524 for cats with feline infectious peritonitis, including how it works, approval status, oral tablet options, product verification, batch traceability, and NeoFipronis® Pronidesivir tablets.
Registered oral GS-441524 tablets for cats, also known as Pronidesivir, with product verification and batch traceability support.
OVERVIEW
GS-441524 is a nucleoside analog antiviral compound widely discussed in relation to feline infectious peritonitis. In the NeoFipronis® product context, GS-441524 is also known as Pronidesivir.
MECHANISM
GS-441524 works by interfering with viral RNA replication. After entering cells, it can be converted into an active form that helps inhibit viral RNA polymerase activity, reducing viral replication.
FIP IN CATS
Feline infectious peritonitis can appear in different forms, including wet FIP, dry FIP, ocular FIP, and neurological FIP. GS-441524 is one of the most discussed antiviral compounds in the FIP community. Product selection and treatment planning should be based on body weight, FIP type, clinical signs, and monitoring results.
REGULATORY STATUS
GS-441524 regulatory status differs by country. Cat owners should understand the difference between FDA approval, compounded availability, and official registration in another country.
GS-441524 is not currently FDA approved as a veterinary drug for FIP in cats. Compounded GS-441524 may be available through veterinary prescription channels under specific conditions.
GS-441524 has been approved in Laos for feline infectious peritonitis. NeoFipronis® is officially registered in Laos as an oral GS-441524 tablet product for cats.
Regulatory status and availability may vary by country. Cat owners should check local regulations and consult veterinary professionals when possible.
ORAL TABLETS
Oral GS-441524 tablets may be easier for cat owners to administer at home compared with injections. When choosing tablets, cat owners should check the active ingredient, tablet strength, batch number, expiry date, verification method, and registration information.
DOSAGE GUIDANCE
GS-441524 dosage is usually calculated based on body weight, FIP type, clinical signs, and treatment response. For many FIP cases, a commonly referenced starting range is 15 mg/kg once daily. Ocular or neurological FIP cases may require higher dosing under professional guidance.
COMPARISON
Both oral and injectable forms require reliable product information and careful monitoring. The right option may depend on the cat’s condition, owner handling ability, product quality, and professional guidance.
| Item | Oral Tablets | Injections |
|---|---|---|
| Administration | Oral use | Subcutaneous injection |
| At-home convenience | Generally easier for many owners | Requires injection handling |
| Stress for cats | Usually lower | May cause stress over time |
| Skin irritation | No injection-site issue | May cause pain or irritation |
| Quality requirement | Source, strength, and batch should be verified | Source, concentration, and batch should be verified |
PRODUCT QUALITY
A reliable GS-441524 product should provide clear product information, traceable batches, and support for verification.
IMPORTANT NOTE
Unclear-source or black-market GS-441524 products may lack consistent labeling, batch documentation, verification support, registration information, or reliable quality control. Cat owners should be cautious with products that cannot clearly show ingredient, strength, batch number, expiry date, or product source.
NEOFIPRONIS®
NeoFipronis® is an oral GS-441524 tablet product for cats. Each tablet contains 30 mg GS-441524, also known as Pronidesivir. NeoFipronis® is officially registered in Laos and supports product verification, batch traceability, and customer guidance.
PRICE TRANSPARENCY
GS-441524 cost can vary depending on cat weight, FIP type, treatment duration, tablet strength, and product source. NeoFipronis® is priced at $168 per box, with 30 tablets per box and 30 mg GS-441524 per tablet.
MONITORING
During GS-441524 use, cat owners commonly monitor body weight, appetite, energy level, temperature, stool condition, bloodwork, albumin/globulin ratio, bilirubin, eye signs, neurological signs, and overall response.
FAQ
GS-441524 is a nucleoside analog antiviral compound widely discussed in relation to feline infectious peritonitis.
In the NeoFipronis® product context, GS-441524 is also known as Pronidesivir.
GS-441524 is widely discussed in the FIP community as an antiviral compound related to feline infectious peritonitis.
GS-441524 is not currently FDA approved as a veterinary drug for FIP in cats in the United States. Compounded GS-441524 may be available through veterinary prescription channels under specific conditions.
GS-441524 has been approved in Laos for feline infectious peritonitis, and NeoFipronis® is officially registered in Laos.
Oral GS-441524 tablet options are available in some markets. Cat owners should check product strength, registration information, batch traceability, and verification support.
NeoFipronis® is an oral GS-441524 tablet product for cats. Each tablet contains 30 mg GS-441524, also known as Pronidesivir.
Unclear-source products may lack ingredient transparency, batch documentation, verification support, registration information, or reliable quality control.
REGISTERED ORAL TABLET OPTION
NeoFipronis® provides 30 mg oral GS-441524 tablets for cats, with official registration in Laos, product verification support, batch traceability, and customer guidance.
loading
